Literature DB >> 11750160

Diarrhoeagenic Escherichia coli--an emerging problem?

S C Clarke1.   

Abstract

Diarrhea remains one of the main sources of morbidity and morbidity in today's world and a large proportion is caused by diarrheagenic Escherichia coli. They are a particular problem in developed countries although traveler's diarrhea and hemorrhagic colitis are also a problem in developed countries. There are seven classes of diarrheagenic E. coli, namely enteropathogenic E. coli (EPEC), enterohaemorrhagic E. coli (EHEC), enteroinvasive E. coli (EIEC), enterotoxigenic E. coli (ETEC), enteroaggregative E. coli (EAggEC), diarrhea-associated hemolytic E. coli (DHEC) and cytolethal distending toxin (CDT)- producing E. coli. Many of their virulence determinants have been determined and some classes of diarrheagenic E. coli produce toxins. The virulence factors of some diarrhogenic E. coli have yet to be full determined and in the meantime they remain a large and emerging problem without the availability of effective vaccines.

Entities:  

Mesh:

Year:  2001        PMID: 11750160     DOI: 10.1016/s0732-8893(01)00303-0

Source DB:  PubMed          Journal:  Diagn Microbiol Infect Dis        ISSN: 0732-8893            Impact factor:   2.803


  37 in total

1.  Occurrence of diarrheagenic Escherichia coli genes in raw water of water treatment plants.

Authors:  Shih-Wei Huang; Bing-Mu Hsu; Yen-Jui Su; Dar-Der Ji; Wei-Chen Lin; Jyh-Larng Chen; Feng-Cheng Shih; Po-Min Kao; Yi-Chou Chiu
Journal:  Environ Sci Pollut Res Int       Date:  2012-02-12       Impact factor: 4.223

2.  Hemolysis in E. coli O104:H4 Infection.

Authors:  Viroj Wiwanitkit
Journal:  Indian J Hematol Blood Transfus       Date:  2011-09-04       Impact factor: 0.900

3.  The enterohemorrhagic Escherichia coli effector protein NleF binds mammalian Tmp21.

Authors:  Rachel L Olsen; Frank Echtenkamp; Dilyara Cheranova; Wanyin Deng; B Brett Finlay; Philip R Hardwidge
Journal:  Vet Microbiol       Date:  2013-02-04       Impact factor: 3.293

4.  Intracellular trafficking of AIP56, an NF-κB-cleaving toxin from Photobacterium damselae subsp. piscicida.

Authors:  Liliana M G Pereira; Rute D Pinto; Daniela S Silva; Ana R Moreira; Christoph Beitzinger; Pedro Oliveira; Paula Sampaio; Roland Benz; Jorge E Azevedo; Nuno M S dos Santos; Ana do Vale
Journal:  Infect Immun       Date:  2014-10-06       Impact factor: 3.441

Review 5.  [Acute diarrheal disease caused by enteropathogenic Escherichia coli in Colombia].

Authors:  Oscar G Gómez-Duarte
Journal:  Rev Chilena Infectol       Date:  2014-10       Impact factor: 0.520

6.  Nitazoxanide inhibits biofilm production and hemagglutination by enteroaggregative Escherichia coli strains by blocking assembly of AafA fimbriae.

Authors:  Eliah R Shamir; Michelle Warthan; Sareena P Brown; James P Nataro; Richard L Guerrant; Paul S Hoffman
Journal:  Antimicrob Agents Chemother       Date:  2010-01-19       Impact factor: 5.191

7.  Antibiotic Sensitivity and Plasmid Profiles of Escherichia coli Isolated from Pediatric Diarrhea.

Authors:  Babu Uma; Kesani Prabhakar; Saddayappan Rajendran; Kannaiyan Kavitha; Yelavarthi Lakshmi Sarayu
Journal:  J Glob Infect Dis       Date:  2009-07

8.  The bacterial virulence factor lymphostatin compromises intestinal epithelial barrier function by modulating rho GTPases.

Authors:  Brian A Babbin; Maiko Sasaki; Kirsten W Gerner-Schmidt; Asma Nusrat; Jan-Michael A Klapproth
Journal:  Am J Pathol       Date:  2009-03-12       Impact factor: 4.307

9.  Role of F1C fimbriae, flagella, and secreted bacterial components in the inhibitory effect of probiotic Escherichia coli Nissle 1917 on atypical enteropathogenic E. coli infection.

Authors:  Sylvia Kleta; Marcel Nordhoff; Karsten Tedin; Lothar H Wieler; Rafal Kolenda; Sibylle Oswald; Tobias A Oelschlaeger; Wilfried Bleiss; Peter Schierack
Journal:  Infect Immun       Date:  2014-02-18       Impact factor: 3.441

10.  Bacterial effector binding to ribosomal protein s3 subverts NF-kappaB function.

Authors:  Xiaofei Gao; Fengyi Wan; Kristina Mateo; Eduardo Callegari; Dan Wang; Wanyin Deng; Jose Puente; Feng Li; Michael S Chaussee; B Brett Finlay; Michael J Lenardo; Philip R Hardwidge
Journal:  PLoS Pathog       Date:  2009-12-24       Impact factor: 6.823

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.